Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6401 USD | -2.75% | +1.28% | +88.15% |
04-16 | Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct | MT |
04-16 | Monopar Therapeutics Inc. Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 11.49M 914M |
---|---|---|---|---|---|
Net income 2024 * | -9M -716M | Net income 2025 * | -10M -796M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.13
x | P/E ratio 2025 * |
-1.46
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.65% |
1 day | -2.75% | ||
1 week | +1.28% | ||
Current month | -6.01% | ||
1 month | -5.73% | ||
3 months | +77.81% | ||
6 months | +58.44% | ||
Current year | +88.15% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 40 | 30/11/14 | |
Kim Tsuchimoto
DFI | Director of Finance/CFO | 61 | 31/05/15 |
Laura Kelly
CTO | Chief Tech/Sci/R&D Officer | - | 17/02/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Brown
BRD | Director/Board Member | 67 | 30/11/14 |
Arthur Klausner
BRD | Director/Board Member | 64 | 31/07/17 |
Kim Tsuchimoto
DFI | Director of Finance/CFO | 61 | 31/05/15 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 0.6401 | -2.75% | 8 492 |
26/04/24 | 0.6582 | +4.89% | 35,008 |
25/04/24 | 0.6275 | -4.49% | 58,241 |
24/04/24 | 0.657 | +1.08% | 39,446 |
23/04/24 | 0.65 | +2.85% | 85,910 |
Delayed Quote Nasdaq, April 29, 2024 at 05:55 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+88.15% | 11.49M | |
+2.73% | 42.75B | |
+47.70% | 41.61B | |
+11.90% | 41.34B | |
-8.83% | 26.59B | |
+7.73% | 25.49B | |
-22.57% | 18.12B | |
+31.06% | 12.24B | |
-1.73% | 11.76B | |
+9.53% | 11B |
- Stock Market
- Equities
- MNPR Stock